| Sandoz Pharmaceuticals AG - Estradot 25, Transdermales Pflaster |
| 55976 | | 05 | | Estradot 25 | | Transdermales Pflaster | | G03CA03 | | Estradiol | | 06.03.2003 | | |
|
| Composition |
| estradiolum 390 µg ut estradiolum hemihydricum, dipropylenglycolum, excipiens ad praeparationem pro 2.5 cm², cum liberatione 25 µg/24 h. |
| Packungsbestandteile |
| Transdermal patch | | | | | | | | Active Agent | Dose |
|---|
| Estradiol | 390 µg correspond Estradiol Hemihydrate |
| | BAG: Active Agent | Dose |
|---|
| Estradiol | 0.39 mg |
| | | | Inactive agents |
|---|
| Dipropylenglycol |
| |
|
|
